These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 616987)

  • 1. [Poisoning by heart-stimulating glycosides. Number of treatment days until the appearance of poisoning].
    Surbat R
    Srp Arh Celok Lek; 1977 Oct; 105(10):845-53. PubMed ID: 616987
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of heart failure, with special consideration of iatrogenic complications].
    Lüderitz B; Avenhaus H
    Munch Med Wochenschr; 1970 Oct; 112(40):1779-84. PubMed ID: 5536213
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacology and therapeutic effects of a new semisynthetic cardioactive glycoside (P1)].
    Königstein RP; Lindner A; Selzer H
    Wien Med Wochenschr; 1971 Jan; 121(4):53-6. PubMed ID: 5103273
    [No Abstract]   [Full Text] [Related]  

  • 5. [The therapy of cardiac insufficiency using Theo-Alvonal].
    Kettermann W
    Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033
    [No Abstract]   [Full Text] [Related]  

  • 6. [Are cardiac glycosides advisable in the treatment of food poisoning].
    Rebenok ZhA
    Ter Arkh; 1988; 60(11):69-71. PubMed ID: 3238582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary report on a clinical trial of peruvoside--a new cardiac glycoside.
    Dalal NJ; Billimoria AR; Vakil NJ; Shah SJ
    Indian Heart J; 1972 Apr; 24(2):129-33. PubMed ID: 4637593
    [No Abstract]   [Full Text] [Related]  

  • 8. [Choice of digitalis glycosides].
    Clément D
    Ther Umsch; 1970 Mar; 27(3):181-4. PubMed ID: 5437616
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of the cardiotonic effects of proscilaridine].
    Netto MP; Forti N; Formicola A; Chryssovergis G; Zillioto EE; Campanari JC; Lunardi W; Giannini SD
    Rev Hosp Clin Fac Med Sao Paulo; 1973; 28(6):300-4. PubMed ID: 4767562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged digitalization without digitalis poisoning].
    Kührt D
    Ther Ggw; 1967 Sep; 106(9):1194 passim. PubMed ID: 5630221
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rare heart rhythm disorders an an early symptom of glycoside intolerance].
    Homola D; Klein KW; Srnová V; Zavrelová V
    Z Gesamte Inn Med; 1968 May; 23(10):293-7. PubMed ID: 5701143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications, contra-indications and dosage of cardiac glycosides controlled by plasma levels in the aged].
    Hötter GJ
    Z Gerontol; 1987; 20(1):8-12. PubMed ID: 3577317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac glycosides: indications, selection and dosage].
    Kuhlmann J
    Med Klin; 1982 Jan; 77(3):18-22. PubMed ID: 7057727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preventive use of glycosides].
    Jahrmärker H
    Internist (Berl); 1973 Jul; 14(7):306-12. PubMed ID: 4270161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principles and directives for practical treatment with cardiac glycosides].
    Dörffel EF
    Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic note on the use of talusin and theo-talusin in ambulatory patients].
    Wirthner H
    Praxis; 1969 Oct; 58(42):1350-1. PubMed ID: 5396158
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with the cardiac glycoside Proscillaridin A (Sandoscill)].
    Amirfallah A; Einert HJ
    Munch Med Wochenschr; 1967 Aug; 109(33):1690-2. PubMed ID: 5631640
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rational prescription of cardiac stimulants].
    Rietbrock N; Abshagen U; von Bergmann K; Kewitz H
    Dtsch Med J; 1972 Feb; 23(2):100-5. PubMed ID: 5017962
    [No Abstract]   [Full Text] [Related]  

  • 19. [Principles of pharmacotherapy with cardiac glycosides].
    Kukes VG; Volkov RIu
    Revmatologiia (Mosk); 1983; (2):65-9. PubMed ID: 6353520
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative studies on the therapeutic range of cardiac glycosides].
    Diederen W; Kadatz R
    Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.